Further, those who were overweight were more than seven times more likely to be diagnosed with NAION, results showed
Malaguarnera, Mariano, et al
This accumulation ratio is important for understanding what happens when you stop: it takes longer to reach "zero" than the simple half-life calculation might suggest because you are clearing accumulated drug, not just the final dose
Recently, the FDA approved them to help manage weight in people dealing with obesity or weight-related health issues
Instead, the two groups landed in about the same place, and when the numbers were crunched, roughly 40% of the GLP-1 groups protection came from something other than the pounds
Patients with BMI under 25 or without obesity diagnoses may still have diabetes, prediabetes, or elevated cardiovascular risk, making them appropriate candidates